Procter & Gamble Stock: Analysts vs. Chart Technicals
Procter & Gamble has faced a tough year in the stock market, with shares falling by nearly 24% in 2025. Despite this decline, major financial firms have started to back the company again after strong financial results in its second fiscal quarter.
The company’s stock has struggled throughout 2025 due to broader economic worries and new tariffs. Investors have continued to sell, pushing the price below all key moving averages. This downward trend has made the upcoming second-quarter results, due on January 22, 2026, a critical moment for the stock’s recovery.
On December 17, 2025, Procter & Gamble reported better-than-expected earnings for its fiscal second quarter. The company also raised its full-year organic sales forecast, pointing to steady consumer demand and improved profit margins. This performance prompted analysts at Goldman Sachs and Morgan Stanley to reaffirm their *buy* ratings on the stock. The same day, Jefferies upgraded its recommendation from *Hold* to *Buy*. Analysts now see an average upside potential of over 18% from current levels, suggesting the stock may be undervalued despite recent challenges.
The renewed support from major banks comes as Procter & Gamble prepares to release its next earnings report. Investors will watch closely to see whether the company’s improved outlook can reverse its stock decline. For now, analysts remain optimistic about its long-term growth prospects.
